MoneyWorks4Me

Medicamen Biotech - Quaterly Results

28 May 2026 Evaluate
An increase of about 110.35% to Rs. 546.81 millions in the total revenue was observed for the quarter ended March 2026. The total revenue was pegged at Rs. 259.95 millions during the similar quarter previous year.Net profit stood at Rs. 29.73  millions  compared to Rs. 24.10 millions in the corresponding previous quarter,high by 23.36%.The company reported a good operating profit of 58.54 millions compared to 41.26 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 546.81 259.95 110.35 1788.46 1514.63 18.08 1788.46 1514.63 18.08
Other Income 17.26 52.20 -66.93 31.04 62.25 -50.14 31.04 62.25 -50.14
PBIDT 58.54 41.26 41.88 213.90 227.83 -6.11 213.90 227.83 -6.11
Interest 5.99 6.23 -3.85 27.84 30.45 -8.57 27.84 30.45 -8.57
PBDT 52.55 35.03 50.01 186.06 197.38 -5.74 186.06 197.38 -5.74
Depreciation 17.25 4.66 270.17 70.59 69.62 1.39 70.59 69.62 1.39
PBT 35.30 30.37 16.23 115.47 127.76 -9.62 115.47 127.76 -9.62
TAX 5.57 6.27 -11.16 21.39 33.27 -35.71 21.39 33.27 -35.71
Deferred Tax -0.95 -0.99 -4.04 -4.09 -3.12 31.09 -4.09 -3.12 31.09
PAT 29.73 24.10 23.36 94.08 94.49 -0.43 94.08 94.49 -0.43
Equity 135.63 127.15 6.67 135.63 127.15 6.67 135.63 127.15 6.67
PBIDTM(%) 10.71 15.87 -32.55 11.96 15.04 -20.49 11.96 15.04 -20.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..